SCHEMBL7532104

SCHEMBL7532104

COc1ccccc1-c1cc2ccccc2[nH]c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.65
▸ ALDH1A1 P00352 4/20 0.65
▸ RAB9A P51151 3/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.65
▸ NPSR1 Q6W5P4 2/20 0.65
▸ HPGD P15428 2/20 0.65
▸ MAPT P10636 2/20 0.65
▸ KDR P35968 2/20 0.57
▸ CHEK1 O14757 1/20 0.57
▸ NPC1 O15118 2/20 0.54
▸ ATM Q13315 1/20 0.54
▸ BRD4 O60885 1/20 0.51
▸ PDGFRB P09619 1/20 0.50
▸ FGFR1 P11362 1/20 0.50
▸ FLT3 P36888 1/20 0.48
▸ DAO P14920 1/20 0.47
▸ DDO Q99489 1/20 0.47
▸ HSD17B10 Q99714 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8925620 0.84 DAO (0.49) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL250338 0.82 BRD4 (0.59) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL31398830 0.82 BRD4 (0.59) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL10973336 0.81 ALDH1A1 (0.65) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL3130132 0.80 HTT (0.46) KDM4EALDH1A1RAB9AMEN1KMT2A
2-(2'-Methoxyphenyl)-1H-Indole SCHEMBL5634916 0.79 KDM4E (1.00) KDM4EALDH1A1RAB9AMEN1KMT2A
2-(2'-Methoxyphenyl)-1H-Indole SCHEMBL31053096 0.79 KDM4E (1.00) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL9384667 0.77 KDM4E (0.63) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL30638485 0.77 SLC6A3 (0.52) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL4553365 0.76 MAPT (0.50) KDM4EALDH1A1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0920319-A4 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO INC (US) 2002-05-02 — — EP disclosed
WO-2001070227-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 2001-09-27 — — WO disclosed
WO-2001070228-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 2001-09-27 — — WO disclosed
US-6162813-A Antagonists of gonadotropin releasing hormone MERCK & CO., INC. (US) 2000-12-19 — — US disclosed
US-6150522-A Antagonists of gonadotropin releasing hormone MERCK & CO., INC. (US) 2000-11-21 — — US disclosed
US-6150352-A ARYLQUINOLONE ANALOGS MERCK & CO., INC. (US) 2000-11-21 — — US disclosed
US-6147088-A USEFUL FOR THE TREATMENT OF A VARIETY OF SEX-HORMONE RELATED CONDITIONS MERCK & CO., INC. (US) 2000-11-14 — — US disclosed
EP-0901471-A4 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO INC (US) 1999-08-25 — — EP disclosed
EP-0918522-A4 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO INC (US) 1999-08-18 — — EP disclosed
EP-0920319-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1999-06-09 — — EP disclosed
EP-0918522-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1999-06-02 — — EP disclosed
EP-0901471-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1999-03-17 — — EP disclosed
EP-0901489-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1999-03-17 — — EP disclosed
WO-1997044321-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-11-27 — — WO disclosed
WO-1997044037-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-11-27 — — WO disclosed
WO-1997044339-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-11-27 — — WO disclosed
WO-1997044041-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-11-27 — — WO disclosed
US-5614532-A NERVOUS SYSTEM DISORDERS USING N-METHYLASPARTATE ANTAGONIST MERCK, SHARP & DOHME LTD. (GB) 1997-03-25 — — US disclosed
Send feedback